Is GBT (GBT) a good stock to buy?

Stable Share Price: GBT's share price has been volatile over the past 3 months. Volatility Over Time: GBT's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.

How much did Global Blood Therapeutics (GBT) raise in an IPO?

Global Blood Therapeutics (GBT) raised $102 million in an IPO on Wednesday, August 12th 2015. The company issued 6,000,000 shares at $16.00-$18.00 per share. Morgan Stanley and Goldman Sachs served as the underwriters for the IPO and Cowen and Company and Wedbush PacGrow were co-managers.

Did Pfizer buy Global Blood Therapeutics (GBT)?

Pfizer Inc. (NYSE:PFE) completed the acquisition of Global Blood Therapeutics, Inc. (NasdaqGS:GBT) from a group of shareholders. Executive Vice President of Operations exercised options to buy US$2.0m worth of stock. Return vs Industry: GBT exceeded the US Biotechs industry which returned -4.2% over the past year.